๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

CHALLENGES IN THE EVALUATION OF SAFETY AND EFFICACY OF HUMAN TISSUE AND CELL BASED PRODUCTS

โœ Scribed by Ming H. Zheng; Richard Pembrey; Silvana Niutta; Patricia Stewart-Richardson; Albert Farrugia


Book ID
108995340
Publisher
John Wiley and Sons
Year
2006
Tongue
English
Weight
441 KB
Volume
76
Category
Article
ISSN
1445-1433

No coin nor oath required. For personal study only.


๐Ÿ“œ SIMILAR VOLUMES


Efficacy and safety of bortezomib in pat
โœ Pellegrino Musto; Fausto Rossini; Francesca Gay; Vincenzo Pitini; Tommasina Gugl ๐Ÿ“‚ Article ๐Ÿ“… 2007 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 104 KB ๐Ÿ‘ 1 views

## Abstract ## BACKGROUND. The prognosis of patients with plasma cell leukemia (PCL), an aggressive variant of multiple myeloma (MM), is usually poor. Bortezomib is the first proteasome inhibitor approved for the treatment of advanced MM. Currently available information regarding the role of borte